Atlas Trials

FXS6837 for the Treatment for IgAN Patients(Longterm Study)

Clinical trial NCT07750665 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07750665
Sponsor
Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Primary IgAN
Start date
2026-09-30
Primary completion
2029-11-13
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.